We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04650581
Brief Title: Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor (FINER)

First Submitted : November 24, 2020
First Submitted that Met QC Criteria : December 1, 2020
First Posted : December 2, 2020

Last Update Submitted that Met QC Criteria : August 8, 2022
Last Update Posted : August 9, 2022